6 Oct 2020

BioVectra's CDMO Capabilities

BioVectra offers contract development and manufacturing capacity for intermediates and active pharmaceutical ingredients (APIs) from five North American cGMP facilities. We specialize in Microbial Fermentation, Complex Chemistry, Biologics, and Formulation Development.

Content provided by our supplier

BioVectra Inc.

  • CA
  • 2015
    On CPHI since
  • 500 - 999
Company types

Other Content from BioVectra Inc. (2)